Please Wait...

Regulatory Medical and Technical Writing

Our in-house team of domain specific subject matter experts help clients produce clear and suitable regulatory documents, detailing all aspects of the drug development process and CMC. Our experts have experience writing clinical study reports, NDA's, ISS/ISE's, and IND applications (including eCTD format).

  • Nonclinical and Clinical Overview Writing
  • CTD Summary Writing
  • Literature Review for Quality/BE studies / Clinical /Non Clinical Overviews
  • Preparation of Summary of Product Characteristic (SmPC), Pack Insert, and Product rationale
  • Proficiency in creating detailed NDA, ANDA, ISS, ISE, and IND applications (Module 1, 2, 3, 4 and 5)
  • Customized Dossier writing
  • Pharmaceutical Development Report (PDR) writing
  • Expert Technical Reports on Quality Module 2.3
  • Dossier updating from old EU format to CTD/eCTD
  • Literature and Brochure for medical devices
  • Annual Safety Report Writing
Regulatory Medical and Technical Writing

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

A great resource for Alzheimers's research teams. https://t.co/qhVP6ImwoO
bioclinica (12 hours ago)
RT @bioclinica: #Pharmacovigilance: Get up-to-speed on latest ind. trends & best practices + hear how others R meeting today's most pressin…
bioclinica (13 hours ago)
RT @Xtalks: Trends in #Pharmacovigilance – Market Research and Future Impact This webinar will discuss an overview of key findings within r…
bioclinica (13 hours ago)
RT @IntClinTrials: Patient loss and can reduced by introducing new methods during the follow-up period. Martin Collyer at @bioclinica tells…
bioclinica (13 hours ago)
@bioclinica experts talk candidly about #Alzheimer's research & where improvements can be made. Joyce Suhy, Marieke… https://t.co/u1Wmu41jRr
bioclinica (13 hours ago)
RT @ACROhealth: @MaryWolleyRA Mary Woolley @ResearchAmerica: 80% have heard of #clinicaltrials. 75% think trial participation is as importa…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen